Moderna Inc.
Organization details
- Legal name
- Moderna Inc.
- Former names
- Moderna Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MRNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001682852
- EIN
- 81-3467528
- Wikidata ID
- Q17081612
Board of directors
-
Abbas Hussain · DirectorSince 2024
-
David M. Rubenstein · DirectorSince 2024
-
Elizabeth E. Tallett · DirectorSince 2023
-
Elizabeth G. Nabel · DirectorSince 2023
-
Francois Nader · DirectorSince 2023
-
Michael R. Mcdonnell · DirectorSince 2026
-
Noubar Afeyan · DirectorSince 2023
-
Paul Sagan · DirectorSince 2023
-
Robert Langer · DirectorSince 2023
-
Sandra Horning · DirectorSince 2023
-
Stephane Bancel · Director · Chief Executive OfficerSince 2023
-
Stephen Berenson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.0%
-
98.5%
Board connections
11 of this board's directors also sit on 15 other boards. 11 are in the same sector.
-
Generate Biomedicines Inc. Same sectorvia Noubar Afeyan and Stephane Bancel
-
Baxter International Inc. Same sectorvia Michael R. Mcdonnell
- via Elizabeth E. Tallett
-
Foghorn Therapeutics Inc. Same sectorvia Noubar Afeyan
-
Gilead Sciences Inc. Same sectorvia Sandra Horning
-
Lyell Immunopharma Inc. Same sectorvia Elizabeth G. Nabel
-
Medtronic plc. Same sectorvia Elizabeth G. Nabel
-
Merit Medical Systems Inc. Same sectorvia Michael R. Mcdonnell
- via Paul Sagan
-
Olema Pharmaceuticals Inc. Same sectorvia Sandra Horning
-
Revolution Medicines Inc. Same sectorvia Sandra Horning
- via Robert Langer
-
Seres Therapeutics Inc. Same sectorvia Stephen Berenson
-
Tectonic Therapeutic Inc. Same sectorvia Francois Nader
- via David M. Rubenstein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $81,648,278
- 22 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,452 | $12.21 | $933,479 |
| Oct 15, 2026 | Hoge Stephen Officer (President) | Open-market sale | −39,145 | $220.72 | $8,640,084 |
| Oct 14, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,453 | $12.21 | $933,491 |
| Oct 14, 2026 | Hoge Stephen Officer (President) | Open-market sale | −38,774 | $213.47 | $8,277,086 |
| Oct 14, 2026 | Hoge Stephen Officer (President) | Open-market sale | −450 | $214.15 | $96,368 |
| Oct 5, 2026 | Mock James M Officer (Chief Financial Officer) | Option exercise | +1,454 | — | — |
| Oct 5, 2026 | Mock James M Officer (Chief Financial Officer) | Shares withheld for tax | −704 | $190.01 | $133,767 |
| Sep 15, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,452 | $12.21 | $933,479 |
| Sep 15, 2026 | Hoge Stephen Officer (President) | Open-market sale | −40,281 | $146.07 | $5,883,846 |
| Sep 14, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,453 | $12.21 | $933,491 |
| Sep 14, 2026 | Hoge Stephen Officer (President) | Open-market sale | −40,294 | $144.13 | $5,807,574 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Option exercise | +19,836 | $30.96 | $614,123 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Open-market sale | −19,836 | $134.49 | $2,667,744 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Open-market sale | −15,000 | $134.49 | $2,017,350 |
| Sep 4, 2026 | Klinger Shannon Thyme Officer (Chief Legal Officer) | Option exercise | +11,797 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Moderna Inc.
Who is the CEO of Moderna Inc.?
Stephane Bancel is Moderna Inc.'s Chief Executive Officer.
How many directors are on Moderna Inc.'s board?
Moderna Inc.'s board has 12 directors: Abbas Hussain, David M. Rubenstein, Elizabeth E. Tallett, Elizabeth G. Nabel, Francois Nader, Michael R. Mcdonnell, Noubar Afeyan, Paul Sagan, Robert Langer, Sandra Horning and 2 others.
Are Moderna Inc. insiders buying or selling shares?
Over the last 12 months, Moderna Inc. insiders made no open-market purchases and sold $81.6 million of shares in 22 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="moderna-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.